Clinical Trials Logo

Filter by:
NCT ID: NCT03866200 Terminated - Clinical trials for Pseudoachondroplasia

Resveratrol Trial for Relief of Pain in Pseudoachondroplasia

Start date: June 29, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if self-administered oral resveratrol can dampen joint pain for individuals with pseudoachondroplasia compared to placebo. Another goal of this study is to evaluate side effects in this population.

NCT ID: NCT03865407 Terminated - Clinical trials for Chronic Kidney Diseases

Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease

Start date: March 10, 2019
Phase: Phase 2
Study type: Interventional

Aim 1. To determine the effect of Allopurinol treatment on renal function (glomerular filtration rate, GFR) in pediatric chronic kidney disease (CKD) patients with high uric acid levels (hyperuricemia). Aim 2. Establish whether Allopurinol treatment reduces Nlrp3 inflammasome and renal injury biomarkers.

NCT ID: NCT03864627 Terminated - Atopic Dermatitis Clinical Trials

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis

GECKO
Start date: March 25, 2019
Phase: Phase 2
Study type: Interventional

To investigate the safety and tolerability of repeated subcutaneous (s.c.) doses of MOR106 administered concomitantly with topical corticosteroids (TCS) in participants with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.

NCT ID: NCT03864328 Terminated - Chronic Cough Clinical Trials

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

SCENIC
Start date: March 29, 2019
Phase: Phase 2
Study type: Interventional

Idiopathic pulmonary fibrosis (IPF) is a rare, progressive life-threatening disease that is characterized by exertional dyspnea and persistent dry cough. Cough in IPF is both a presenting and a complicating clinical feature, which affects approximately three quarters of IPF cases. It is often a debilitating symptom that adversely affects quality of life (QoL) and is usually refractory to medical therapy. Inhaled RVT-1601 (formerly, PA101B), a new inhalation formulation of cromolyn sodium delivered via the eFlow® Closed System (CS) nebulizer, is being evaluated in this Phase 2b study for the treatment of persistent cough in patients with IPF.

NCT ID: NCT03863639 Terminated - Pre-Eclampsia Clinical Trials

Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia

Start date: July 7, 2014
Phase:
Study type: Observational

This is a pilot study assessing fMRI changes and neurocognitive function in women with pre-eclampsia and healthy controls. Neurocognitive testing will be done during pregnancy and after delivery up to 2-6 weeks postpartum. fMRI will be done after delivery up to 2-6 weeks postpartum. The aims of this pilot study are therefore to 1) Determine the frequency and nature of co-morbid DTI white matter patency and fMRI functional connectivity changes in women with pre-eclampsia/eclampsia and 2) Determine the relationship between DTI white matter patency and fMRI functional connectivity changes to measurable alterations in cognitive function in this patient population. The aims of this pilot study are therefore to 1) Determine the frequency and nature of co-morbid DTI white matter patency and fMRI functional connectivity changes in women with pre-eclampsia/eclampsia and 2) Determine the relationship between DTI white matter patency and fMRI functional connectivity changes to measurable alterations in cognitive function in this patient population.

NCT ID: NCT03863522 Terminated - Clinical trials for Breast Cancer Diagnosis

Automated Method for Breast Cancer Detection

Start date: March 7, 2019
Phase: N/A
Study type: Interventional

Participants with suspicious breast lesions by mammography will undergo fine needle aspiration (FNA) under ultrasound guidance. The FNA will be read by the cytopathologist and analyzed in the breast cancer detection cartridge. All patients will receive standard of care (Ultrasound-guided core needle biopsy and diagnosis). We will also receive FNA collected from 60 patients with palpable lesions in South Africa and analyze them samples in our lab with the same method.

NCT ID: NCT03863288 Terminated - Irritable Mood Clinical Trials

Dose Response Relationship of Oxytocin on Irritability in Youths

Start date: February 18, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The proposed study is a randomized, double-blind proof of concept (PoC) study on the neural impact of intranasal oxytocin (OXT) administration for adolescents (age 14 to 18), demonstrating a clinically significant level of irritability as defined by a score of ≥4 on the Affective Reactivity Index (ARI). Planned enrollment is 80 subjects over 3 years.

NCT ID: NCT03862066 Terminated - Clinical trials for Squamous Cell Carcinoma of the Head and Neck

Memory Phenotype and PD-1 Inhibition Response in Oral Cancer

Start date: February 8, 2019
Phase:
Study type: Observational

The purpose of this research study is collect tissue and blood samples from patients who are having surgery and use those samples in lab studies to see if there are any markers in blood and tissue that can help predict how cancer will react to different treatment. Participants in this study will have a blood sample and tissue samples collected for research. The blood and tissue collected will be tested in the laboratory. The tissue collected will be left over tissue from the standard of care surgery.

NCT ID: NCT03862040 Terminated - Bacterial Pneumonia Clinical Trials

Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia

Start date: February 20, 2019
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to determine the degree of penetration of cefiderocol into infected lung tissue in hospitalized adults with bacterial pneumonia who are being mechanically ventilated.

NCT ID: NCT03862027 Terminated - Respiratory Failure Clinical Trials

Safety of Optimal PEEP in NSICU Patients

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The investigators aim to demonstrate that use of transpulmonary pressure to guide PEEP management is safe in patients with possible elevations of intracranial pressure.